A STUDY OF FASTING AND POSTPRANDIAL LIPID ABNORMALITIES IN TYPE 2 DIABETES MELLITUS

被引:0
|
作者
Babu, R. [1 ]
Varghese, Shigil Mathew [1 ]
Ramireddy, Seetha M. [1 ]
Kumar, Arun S. [1 ]
Bala, Ramesh A. [1 ]
机构
[1] Vinayaka Missions Med Coll & Hosp, Dept Gen Med, Karaikal, India
关键词
Dyslipidaemia; Prandial Lipid; VLDL-C Level; Diabetic Patients; and HDL-C;
D O I
10.14260/jemds/2016/965
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
AIM 1. To assess the nature of fasting dyslipidaemia in type 2 diabetes mellitus and correlate the same with severity and duration of diabetes. 2. To assess the postprandial lipid abnormalities in type 2 diabetes and to compare it with that of the fasting lipid load in diabetics. METHODS The study was carried out in Vinayaka Missions Medical College and Hospital, Karaikal over a period of 2 years. A total of 50 patients with type 2 diabetes mellitus were included and were compared with 50 age and sex matched healthy controls fulfilling the inclusion and exclusion criteria. RESULTS In this study, the mean age +/- SD was 48.5 +/- 5.68 years. The mean HbA1c +/- SD was 7.48 +/- 1.517. All cases in fasting state had raised VLDL-C levels (Mean 50.39 +/- 60.27), raised total cholesterol (Mean 169.70 +/- 39.917), raised TGL (Mean 146.04 +/- 60.140), decreased LDL-C (Mean 92.3 +/- 27.699) when compared to control group. In the postprandial state, there was a significant raise in TGL level (Mean 188 +/- 68.59), raised total cholesterol (Mean180.74 +/- 38.46), decreased HDL-C (Mean 38.761 +/- 9.028) compared to the fasting state. CONCLUSION It was found that there was a raised in TGL levels in the postprandial state, raised VLDL-C and reduced LDL-C in fasting state, raised total cholesterol and reduced HDL-C seen in both fasting and postprandial statesof diabetic patients.
引用
收藏
页码:4234 / 4238
页数:5
相关论文
共 50 条
  • [21] SULF2 Strongly Prediposes to Fasting and Postprandial Triglycerides in Patients with Obesity and Type 2 Diabetes Mellitus
    Hassing, H. Carlijne
    Surendran, R. Preethi
    Derudas, Bruno
    Verrijken, An
    Francque, Sven M.
    Mooij, Hans L.
    Moens, Sophie J. Bernelot
    ' t Hart, Leen M.
    Nijpels, Giel
    Dekker, Jacqueline M.
    Williams, Kevin Jon
    Stroes, Erik S. G.
    Van Gaal, Luc F.
    Staels, Bart
    Nieuwdorp, Max
    Dallinga-Thie, Geesje M.
    [J]. OBESITY, 2014, 22 (05) : 1309 - 1316
  • [22] Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
    Voukali, Maria
    Kastrinelli, Irene
    Stragalinou, Sapfo
    Tasiopoulou, Dimitra
    Paraskevopoulou, Pinelopi
    Katsilambros, Nicholas
    Kokkinos, Alexandros
    Tentolouris, Nicholas
    Ioannidis, Ioannis
    [J]. JOURNAL OF DIABETES RESEARCH, 2014, 2014
  • [23] ASSESSMENT OF LIPID ABNORMALITIES AND CARDIOVASCULAR RISK INDICES IN TYPE 2DIABETES MELLITUS
    Baral, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A209 - A210
  • [24] Postprandial lipid profile in patients with type 2 diabetes
    Katsiki, Niki
    Kolovou, Genovefa
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 121 - 121
  • [25] Effect of glycine on insulin secretion, fasting and postprandial glucose levels in patients with Type 2 diabetes mellitus.
    Martínez-Abundis, E
    Kam-Ramos, AM
    Hernández-Salazar, E
    González-Ortiz, M
    [J]. DIABETOLOGIA, 2003, 46 : A261 - A262
  • [26] Fasting plasma glucose concentrations correlate highly with postprandial glycemic responses in patients with type 2 diabetes mellitus
    Abbasi, F
    Chu, JW
    Lamendola, C
    McLaughlin, T
    Schaaf, P
    Reaven, GM
    [J]. DIABETES, 2002, 51 : A591 - A591
  • [27] Agreement Between Fasting and Postprandial LDL Cholesterol Measured with 3 Methods in Patients with Type 2 Diabetes Mellitus
    Lund, Soren S.
    Petersen, Martin
    Frandsen, Merete
    Smidt, Ulla M.
    Parving, Hans-Henrik
    Vaag, Allan A.
    Jensen, Tonny
    [J]. CLINICAL CHEMISTRY, 2011, 57 (02) : 298 - 308
  • [28] Intermittent Fasting for Patients with Type 2 Diabetes mellitus
    Pavlicek, Vojtech
    [J]. DIABETOLOGIE, 2023, 20 (1): : 154 - 155
  • [29] LIPID ABNORMALITIES IN DIABETES-MELLITUS
    VERGES, B
    [J]. REVUE DE MEDECINE INTERNE, 1991, 12 (04): : 277 - 281
  • [30] SERUM LIPID ABNORMALITIES IN DIABETES MELLITUS
    SULLIVAN, JF
    LANKFORD, HG
    GRINNELL, EH
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1965, 7 (01): : 28 - &